R
Oggetto: In Memoriam: Judah Folkman, M.D.
Da: “AACR Updates”
Data: Mar, 15 Gennaio 2008, 11:17 pm

Judah Folkman, M.D. (1933-2008)

Judah Folkman, M.D., director of the vascular biology program at Children’s

Hospital Boston and the Andrus professor of pediatric surgery and professor of cell
biology at Harvard Medical School, died suddenly January 14, 2008. He was 74.

Internationally renowned as a pioneer in the field of angiogenesis research, Dr.

Folkman’s landmark discovery that cutting off a cancerous tumor’s blood supply
inhibited its growth and ability to spread revolutionized cancer treatment. Dr.
Folkman’s laboratory was the first to purify angiogenic protein from a tumor, basic

research which led to the discovery of the first angiogenesis inhibitors and
ultimately to clinical trials of anti-angiogenic therapy. Today, angiogenesis
inhibitors such as Avastin, Tarceva and Macugen have received FDA approval in the

U.S. and similar regulatory approval in 27 other countries for the treatment of
cancer and/or macular degeneration. Dr. Folkman’s research provides a firm
scientific foundation for the pursuit of anti-angiogenic therapy, not only for the

treatment of cancer, but for many non-neoplastic diseases.

“Judah Folkman’s passing is a tremendous and tragic loss for humankind,” said
AACR Chief Executive Officer Margaret Foti, Ph.D., M.D. (h.c.). “In addition to

his brilliant and distinguished cancer research career, Judah was highly regarded by
the cancer community as a supportive mentor, a dedicated teacher, and esteemed
colleague. His legacy of discovery and ingenuity in the field of angiogenesis will

continue to inspire cancer researchers and give hope to countless individuals living
with the disease. He was certainly a valued friend of the AACR and we extend our
deepest condolences to the Folkman family.”

An active member of the American Association for Cancer Research since 1990, Dr.
Folkman served as an associate editor of two AACR journals, Cancer Research (1990
– 2000) and Clinical Cancer Research (1999 – 2002). He was the 1985 recipient

of the AACR- G.H.A. Clowes Memorial Award in recognition of his outstanding
accomplishments in cancer research. Dr. Folkman also demonstrated his commitment to
cancer research philanthropy as a trustee of the AACR Foundation for the Prevention

and Cure of Cancer.

Through his work with the AACR and through leadership and advisory positions with a
host of prestigious scientific institutions and organizations such as the National
Institutes of Health, The National Academy of Sciences, the Institute of Medicine

and the American Pediatric Surgical Association, Dr. Folkman helped to define the
field of cancer and biomedical research.